He leads a team of nearly 200 scientists and over 600 research staff committed to making discoveries to improve the quality of life for people served by CAMH, and beyond, through brain science, clinical research, health services research, and policy and population health research. Dr. Voineskos has an outstanding track-record as a clinician, a scientist, and a leader, driving change to improve care for people with mental illness.

Dr. Voineskos is known for his international research leadership in psychosis and schizophrenia, serving on the editorial board of Schizophrenia Bulletin, and as the co-Chair of the Schizophrenia International Research Society 2021 meeting. He has published over 200 papers, many of which are in the leading journals of psychiatry, neurology, medicine, and neuroscience. In addition, he is known for his leadership on large-scale international multi-centre research initiatives across disciplines funded by the Canadian Institutes of Health Research and National Institute of Mental Health in the United States.